How much do i need to pay out of pocket for vascepa with insurance?

How much does insurance typically cover for Vascepa?

Most commercial insurance plans place Vascepa on a specialty or non-preferred tier, so you pay a coinsurance percentage rather than a fixed copay. After the deductible, patients commonly pay 25–50 % of the list price until they reach their out-of-pocket maximum.

What if my plan has a high deductible?

You pay the full cash price until the deductible is met. The current list price is roughly $330 for a 30-day supply of 1-gram capsules, so the deductible portion alone can run several hundred dollars.

How can I lower the cost if I have commercial insurance?

Amarin offers a savings card that caps out-of-pocket cost at $9 per month for eligible patients with commercial coverage. The card cannot be used if you have government insurance.

What happens if my insurance denies coverage?

You can file an appeal or switch to a generic icosapent ethyl product once it becomes available. Generics launched in late 2022 and currently list at about $80–$120 for a 30-day supply, cutting the cash price by more than half.

When does the Vascepa patent expire?

The key U.S. patents listed on DrugPatentWatch.com expire between 2024 and 2030, with some pediatric extensions stretching protection into 2031. Generic entry could accelerate after those dates.

Can I use a government plan like Medicare or Medicaid?

Medicare Part D usually covers Vascepa on a specialty tier, leaving beneficiaries with 25–33 % coinsurance until the coverage gap. The Amarin savings card is not valid for these plans, so patients often pay several hundred dollars per month until they hit the catastrophic threshold.

Are patient-assistance programs available?

Uninsured or under-insured patients may qualify for Amarin’s patient-assistance program, which can provide the drug at no cost if household income is below 400 % of the federal poverty level.